Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).

Chia-Jui YenNaomi KiyotaNobuhiro HanaiShunji TakahashiTomoya YokotaShigemichi IwaeYasushi ShimizuRuey-Long HongMasahiro GotoJin-Hyoung KangWing Sum Kenneth LiMatthew J FerrisMaura GillisonToshimitsu EndoVijayvel JayaprakashMakoto Tahara

Published in: Head & neck (2020)

NCT02105636.

Keyphrases

phase iii
squamous cell carcinoma
clinical trial
open label
phase ii
double blind
small cell lung cancer
placebo controlled
lymph node metastasis
locally advanced
decision making
radiation therapy
bone marrow
rectal cancer